Solvay, Watson Say AndroGel Deals Are Legal
Solvay Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. are aiming to throw out the Federal Trade Commission's suit that alleges patent settlements over the testosterone supplement AndroGel restrained competition, arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article